{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:42:56Z","timestamp":1769838176654,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Indonesia Endowment Fund"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cmi.2018.10.009","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T22:04:55Z","timestamp":1540591495000},"page":"761.e1-761.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study"],"prefix":"10.1016","volume":"25","author":[{"given":"I.S.","family":"Pradipta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"van't Boveneind-Vrubleuskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.W.","family":"Akkerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.C.","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.10.009_bib1","series-title":"Framework towards tuberculosis elimination in low-incidence countries","author":"World Health Organization (WHO)","year":"2014"},{"key":"10.1016\/j.cmi.2018.10.009_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/ers.10.7","article-title":"Tuberculosis in Europe: a problem of drug resistance or much more?","volume":"4","author":"Carvalho","year":"2010","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.cmi.2018.10.009_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1469-0691.2010.03358.x","article-title":"Impact of immigration on tuberculosis epidemiology in a low-incidence country","volume":"17","author":"Svensson","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.10.009_bib4","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.12.30489","article-title":"Ending tuberculosis in risk groups in Europe: challenges from travel and population movement","volume":"22","author":"Jackson","year":"2017","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.cmi.2018.10.009_bib5","series-title":"Tuberculosis surveillance and monitoring in Europe","year":"2018"},{"key":"10.1016\/j.cmi.2018.10.009_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1034\/j.1399-3003.2000.16b05.x","article-title":"Defaulting from tuberculosis treatment in The Netherlands: rates, risk factors and trend in the period 1993\u20131997","volume":"16","author":"Borgdorff","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2018.10.009_bib7","series-title":"Definitions and reporting framework for tuberculosis \u2013 2013 revision","author":"WHO","year":"2013"},{"key":"10.1016\/j.cmi.2018.10.009_bib8","series-title":"Handboek tuberculose 2015","author":"de Vries","year":"2015"},{"key":"10.1016\/j.cmi.2018.10.009_bib9","series-title":"Osiris-NTR Tuberculose ziekte Vragenlijst en handleiding Voorwaarden registratie van Tuberculose","first-page":"1","year":"2017"},{"key":"10.1016\/j.cmi.2018.10.009_bib10","series-title":"Clinical prediction models","author":"Steyerberg","year":"2009"},{"key":"10.1016\/j.cmi.2018.10.009_bib11","first-page":"109","article-title":"STROBE statement","volume":"13","author":"Kumar","year":"2011","journal-title":"JK Sci"},{"key":"10.1016\/j.cmi.2018.10.009_bib12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/519841","article-title":"The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis","volume":"45","author":"Alisjahbana","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib13","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/507543","article-title":"Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes","volume":"43","author":"Nijland","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4269\/ajtmh.2009.80.634","article-title":"Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis","volume":"80","author":"Dooley","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2018.10.009_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-10-36","article-title":"Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial","volume":"10","author":"Christopoulos","year":"2009","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.cmi.2018.10.009_bib16","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1469-0691.2011.03473.x","article-title":"Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study","volume":"17","author":"Li","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.10.009_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5588\/ijtld.13.0726","article-title":"Impact of chronic renal failure on anti-tuberculosis treatment outcomes","volume":"18","author":"Baghaei","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijid.2016.11.407","article-title":"Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa","volume":"54","author":"Kigozi","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib19","first-page":"458","article-title":"Current status of treatment completion and fatality among tuberculosis patients in Spain","volume":"8","author":"Cayla","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib20","series-title":"National Tuberculosis Control Plan 2011\u20132015","author":"de Boer","year":"2011"},{"key":"10.1016\/j.cmi.2018.10.009_bib21","series-title":"National tuberculosis control plan 2016\u20132020: towards elimination","author":"de Vries","year":"2016"},{"key":"10.1016\/j.cmi.2018.10.009_bib22","volume":"vol. 57","year":"2015"},{"key":"10.1016\/j.cmi.2018.10.009_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jctube.2017.02.002","article-title":"Policy and practice of programmatic management of latent tuberculosis infection in The Netherlands","volume":"7","author":"de Vries","year":"2017","journal-title":"J\u00a0Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib24","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/S1473-3099(16)30531-X","article-title":"Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literature","volume":"17","author":"de Vries","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1086\/594126","article-title":"Tuberculosis and illicit drug use: review and update","volume":"48","author":"Deiss","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cmi.2017.09.012","article-title":"Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study","volume":"24","author":"Javaid","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.10.009_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cmi.2017.07.008","article-title":"Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009\u20132013","volume":"24","author":"Zhang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.10.009_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-14-360","article-title":"Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005\u20132012","volume":"14","author":"Choi","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.10.009_bib29","first-page":"124","article-title":"Outcome of tuberculosis treatment in Hamburg: A survey, 1997\u20132001","volume":"7","author":"Diel","year":"2003","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18307122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18307122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:22:19Z","timestamp":1761117739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18307122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1198743X18307122"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.10.009","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}